Differential effects of nasal continuous positive airway pressure on reversible or fixed upper and lower airway obstruction

C. H. Wang, H. C. Lin, T. J. Huang, C. T. Yang, C. T. Yu, H. P. Kuo

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Our study was to assess whether there were differential effects of nasal continuous positive airway pressure (nCPAP) on different kinds of obstruction in either upper or lower airways in patients with chronic obstructive pulmonary disease (COPD). nCPAP (6 cmH2O for ten minutes) was applied to 7 patients with reversible extrathoracic upper airway obstruction (RUAO) and 3 patients with fixed extrathoracic upper airway obstruction (FUAO). Eighteen stable asthmatics, receiving methacholine challenge to induce a more than 20% reduction in FEV1, were randomly investigated for the effect of nCPAP or sham pressure on reversible lower airway obstruction. Nine stable COPD patients were enrolled to study the effect on irreversible lower airway obstruction. Maximal expiratory and inspiratory flow volume curves and dyspnoea scores were obtained before and after immediate withdrawal of nCPAP. In the RUAO group, nCPAP significantly improved stridor and dyspnoea scores, decreased the ratio of FEF50/FIF50 from 2.05±0.25 to 1.42±0.16, and increased peak inspiratory flow (PIF) as well as forced inspiratory vital capacity by 26±8% and 9±4%, respectively. In expiratory phase, there was no significant change in pulmonary functions. In asthmatics, nCPAP significantly reversed methacholine-induced bronchoconstriction increasing forced vital capacity by 10±3%, FEV1 by 15±4% and PIF by 32±11%. nCPAP significantly increased the response to bronchodilators. The improvement in airflow rate persisted for at least 5 min after nCPAP withdrawal and was highly correlated with the response to bronchodilators. There was no significant effect of nCPAP on airflow rate in COPD patients. Subjective dyspnoea score changes paralleled the pulmonary function improvement. We conclude that there are differential effects of nCPAP on airflow rates in patients with different nature of airway obstruction. Patients with airway obstruction caused by structural changes may not benefit from the use of nCPAP in improving airflow rates.

Original languageEnglish
Pages (from-to)952-959
Number of pages8
JournalEuropean Respiratory Journal
Volume9
Issue number5
DOIs
Publication statusPublished - May 1 1996
Externally publishedYes

Fingerprint

Continuous Positive Airway Pressure
Airway Obstruction
Dyspnea
Chronic Obstructive Pulmonary Disease
Methacholine Chloride
Bronchodilator Agents
Vital Capacity
Maximal Expiratory Flow-Volume Curves
Inspiratory Capacity
Lung
Bronchoconstriction
Respiratory Sounds

Keywords

  • Airway obstruction
  • nasal continuous positive airway pressure
  • respiratory function tests

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Differential effects of nasal continuous positive airway pressure on reversible or fixed upper and lower airway obstruction. / Wang, C. H.; Lin, H. C.; Huang, T. J.; Yang, C. T.; Yu, C. T.; Kuo, H. P.

In: European Respiratory Journal, Vol. 9, No. 5, 01.05.1996, p. 952-959.

Research output: Contribution to journalArticle

Wang, C. H. ; Lin, H. C. ; Huang, T. J. ; Yang, C. T. ; Yu, C. T. ; Kuo, H. P. / Differential effects of nasal continuous positive airway pressure on reversible or fixed upper and lower airway obstruction. In: European Respiratory Journal. 1996 ; Vol. 9, No. 5. pp. 952-959.
@article{53834fa4078243eea2b539e2f6389faf,
title = "Differential effects of nasal continuous positive airway pressure on reversible or fixed upper and lower airway obstruction",
abstract = "Our study was to assess whether there were differential effects of nasal continuous positive airway pressure (nCPAP) on different kinds of obstruction in either upper or lower airways in patients with chronic obstructive pulmonary disease (COPD). nCPAP (6 cmH2O for ten minutes) was applied to 7 patients with reversible extrathoracic upper airway obstruction (RUAO) and 3 patients with fixed extrathoracic upper airway obstruction (FUAO). Eighteen stable asthmatics, receiving methacholine challenge to induce a more than 20{\%} reduction in FEV1, were randomly investigated for the effect of nCPAP or sham pressure on reversible lower airway obstruction. Nine stable COPD patients were enrolled to study the effect on irreversible lower airway obstruction. Maximal expiratory and inspiratory flow volume curves and dyspnoea scores were obtained before and after immediate withdrawal of nCPAP. In the RUAO group, nCPAP significantly improved stridor and dyspnoea scores, decreased the ratio of FEF50/FIF50 from 2.05±0.25 to 1.42±0.16, and increased peak inspiratory flow (PIF) as well as forced inspiratory vital capacity by 26±8{\%} and 9±4{\%}, respectively. In expiratory phase, there was no significant change in pulmonary functions. In asthmatics, nCPAP significantly reversed methacholine-induced bronchoconstriction increasing forced vital capacity by 10±3{\%}, FEV1 by 15±4{\%} and PIF by 32±11{\%}. nCPAP significantly increased the response to bronchodilators. The improvement in airflow rate persisted for at least 5 min after nCPAP withdrawal and was highly correlated with the response to bronchodilators. There was no significant effect of nCPAP on airflow rate in COPD patients. Subjective dyspnoea score changes paralleled the pulmonary function improvement. We conclude that there are differential effects of nCPAP on airflow rates in patients with different nature of airway obstruction. Patients with airway obstruction caused by structural changes may not benefit from the use of nCPAP in improving airflow rates.",
keywords = "Airway obstruction, nasal continuous positive airway pressure, respiratory function tests",
author = "Wang, {C. H.} and Lin, {H. C.} and Huang, {T. J.} and Yang, {C. T.} and Yu, {C. T.} and Kuo, {H. P.}",
year = "1996",
month = "5",
day = "1",
doi = "10.1183/09031936.96.09050952",
language = "English",
volume = "9",
pages = "952--959",
journal = "European Respiratory Journal",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "5",

}

TY - JOUR

T1 - Differential effects of nasal continuous positive airway pressure on reversible or fixed upper and lower airway obstruction

AU - Wang, C. H.

AU - Lin, H. C.

AU - Huang, T. J.

AU - Yang, C. T.

AU - Yu, C. T.

AU - Kuo, H. P.

PY - 1996/5/1

Y1 - 1996/5/1

N2 - Our study was to assess whether there were differential effects of nasal continuous positive airway pressure (nCPAP) on different kinds of obstruction in either upper or lower airways in patients with chronic obstructive pulmonary disease (COPD). nCPAP (6 cmH2O for ten minutes) was applied to 7 patients with reversible extrathoracic upper airway obstruction (RUAO) and 3 patients with fixed extrathoracic upper airway obstruction (FUAO). Eighteen stable asthmatics, receiving methacholine challenge to induce a more than 20% reduction in FEV1, were randomly investigated for the effect of nCPAP or sham pressure on reversible lower airway obstruction. Nine stable COPD patients were enrolled to study the effect on irreversible lower airway obstruction. Maximal expiratory and inspiratory flow volume curves and dyspnoea scores were obtained before and after immediate withdrawal of nCPAP. In the RUAO group, nCPAP significantly improved stridor and dyspnoea scores, decreased the ratio of FEF50/FIF50 from 2.05±0.25 to 1.42±0.16, and increased peak inspiratory flow (PIF) as well as forced inspiratory vital capacity by 26±8% and 9±4%, respectively. In expiratory phase, there was no significant change in pulmonary functions. In asthmatics, nCPAP significantly reversed methacholine-induced bronchoconstriction increasing forced vital capacity by 10±3%, FEV1 by 15±4% and PIF by 32±11%. nCPAP significantly increased the response to bronchodilators. The improvement in airflow rate persisted for at least 5 min after nCPAP withdrawal and was highly correlated with the response to bronchodilators. There was no significant effect of nCPAP on airflow rate in COPD patients. Subjective dyspnoea score changes paralleled the pulmonary function improvement. We conclude that there are differential effects of nCPAP on airflow rates in patients with different nature of airway obstruction. Patients with airway obstruction caused by structural changes may not benefit from the use of nCPAP in improving airflow rates.

AB - Our study was to assess whether there were differential effects of nasal continuous positive airway pressure (nCPAP) on different kinds of obstruction in either upper or lower airways in patients with chronic obstructive pulmonary disease (COPD). nCPAP (6 cmH2O for ten minutes) was applied to 7 patients with reversible extrathoracic upper airway obstruction (RUAO) and 3 patients with fixed extrathoracic upper airway obstruction (FUAO). Eighteen stable asthmatics, receiving methacholine challenge to induce a more than 20% reduction in FEV1, were randomly investigated for the effect of nCPAP or sham pressure on reversible lower airway obstruction. Nine stable COPD patients were enrolled to study the effect on irreversible lower airway obstruction. Maximal expiratory and inspiratory flow volume curves and dyspnoea scores were obtained before and after immediate withdrawal of nCPAP. In the RUAO group, nCPAP significantly improved stridor and dyspnoea scores, decreased the ratio of FEF50/FIF50 from 2.05±0.25 to 1.42±0.16, and increased peak inspiratory flow (PIF) as well as forced inspiratory vital capacity by 26±8% and 9±4%, respectively. In expiratory phase, there was no significant change in pulmonary functions. In asthmatics, nCPAP significantly reversed methacholine-induced bronchoconstriction increasing forced vital capacity by 10±3%, FEV1 by 15±4% and PIF by 32±11%. nCPAP significantly increased the response to bronchodilators. The improvement in airflow rate persisted for at least 5 min after nCPAP withdrawal and was highly correlated with the response to bronchodilators. There was no significant effect of nCPAP on airflow rate in COPD patients. Subjective dyspnoea score changes paralleled the pulmonary function improvement. We conclude that there are differential effects of nCPAP on airflow rates in patients with different nature of airway obstruction. Patients with airway obstruction caused by structural changes may not benefit from the use of nCPAP in improving airflow rates.

KW - Airway obstruction

KW - nasal continuous positive airway pressure

KW - respiratory function tests

UR - http://www.scopus.com/inward/record.url?scp=0030008530&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030008530&partnerID=8YFLogxK

U2 - 10.1183/09031936.96.09050952

DO - 10.1183/09031936.96.09050952

M3 - Article

VL - 9

SP - 952

EP - 959

JO - European Respiratory Journal

JF - European Respiratory Journal

SN - 0903-1936

IS - 5

ER -